کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1904965 | 1534686 | 2012 | 7 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging](/preview/png/1904965.png)
We assessed the relationship of insulin resistance with cognitive decline and brain atrophy over two years in early Alzheimer's disease (AD, n = 48) and nondemented controls (n = 61). Intravenous glucose tolerance tests were conducted at baseline to determine insulin area-under-the-curve (AUC). A standard battery of cognitive tasks and MRI were conducted at baseline and 2-year follow-up. In nondemented controls, higher baseline insulin AUC was associated with 2-year decline in global cognitive performance (beta = − 0.36, p = 0.005). In early AD, however, higher insulin AUC was associated with less decline in global cognitive performance (beta = 0.26, p = 0.06), slower global brain atrophy (beta = 0.40, p = 0.01) and less regional atrophy in the bilateral hippocampi and cingulate cortices. While insulin resistance is associated with cognitive decline in nondemented aging, higher peripheral insulin may have AD-specific benefits or insulin signaling may be affected by systemic physiologic changes associated with AD. This article is part of a Special Issue entitled: Imaging Brain Aging and Neurodegenerative disease.
► Peripheral insulin, cognitive change, and brain atrophy in aging and Alzheimer's.
► Higher insulin in aging is associated with greater 2-year decline in cognition.
► Higher insulin in AD is associated with less cognitive decline and brain atrophy.
Journal: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease - Volume 1822, Issue 3, March 2012, Pages 333–339